$A rapid, computational approach for assessing interfraction esophageal motion for use in stereotactic body radiation therapy planning$

A rapid, computational approach for assessing interfraction esophageal motion for use in stereotactic body radiation therapy planning

Purpose: We present a rapid computational method for quantifying interfraction motion of the esophagus in patients undergoing stereotactic body radiation therapy on a magnetic resonance (MR) guided radiation therapy system. Methods and materials: Patients who underwent stereotactic body radiation th...

Full description

Bibliographic Details
Main Authors:	Michael L. Cardenas, MD, Thomas R. Mazur, PhD, Christina I. Tsien, MD, Olga L. Green, PhD
Format:	Article
Language:	English
Published:	Elsevier 2018-04-01
Series:	Advances in Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2452109417301987

Similar Items

Influence of intra- and interfraction motion on planning target volume margin in liver stereotactic body radiation therapy using breath hold
by: Patricia A.K. Oliver, PhD, et al.
Published: (2021-01-01)

Spatially fractionated stereotactic body radiation therapy (Lattice) for large tumors
by: Sai Duriseti, MD, PhD, et al.
Published: (2021-05-01)

Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
by: Pierre-Marie Pialat, MD, et al.
Published: (2021-07-01)

Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost in Patients With Spinal Metastases
by: Antonio Pontoriero MD, et al.
Published: (2020-04-01)

Interfraction variation in lung tumor position with abdominal compression during stereotactic body radiotherapy
by: Mampuya Wambaka Ange
Published: (2014)

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy
by: Dawn Owen, MD, PhD, et al.
Published: (2016-01-01)

Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy
by: Megumi Uto, et al.
Published: (2021-07-01)

Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
by: Comron Hassanzadeh, MD, MPH, et al.
Published: (2021-01-01)

Fractionated stereotactic radiation therapy for intact brain metastases
by: Samuel R. Marcrom, MD, et al.
Published: (2017-10-01)

Brain metastases with poor vascular function are susceptible to pseudoprogression after stereotactic radiation surgery
by: Ingrid Digernes, MSc, et al.
Published: (2018-10-01)

Deep Learning–Based Fluence Map Prediction for Pancreas Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost
by: Wentao Wang, MS, et al.
Published: (2021-07-01)

Esophageal motion characteristics in thoracic esophageal cancer: Impact of clinical stage T4 versus stages T1-T3
by: Yuta Kobayashi, MS, et al.
Published: (2016-10-01)

Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma
by: Jonathan E. Schoenhals, BS, et al.
Published: (2021-09-01)

Clinical Outcomes Using Magnetic Resonance–Guided Stereotactic Body Radiation Therapy in Patients With Locally Advanced Cholangiocarcinoma
by: Elaine Luterstein, BS, et al.
Published: (2020-03-01)

Comprehensive assessment of circulating immune cell populations in response to stereotactic body radiation therapy in patients with liver cancer
by: Michael P. Gustafson, PhD, et al.
Published: (2017-10-01)

Practical Considerations for the Implementation of a Stereotactic Body Radiation Therapy Program for Oligo-Metastases
by: Matthew Chan, MD, FRCPC, et al.
Published: (2021-01-01)

Interfractional Variations of Tumor Centroid Position and Tumor Regression during Stereotactic Body Radiotherapy for Lung Tumor
by: Yanan Sun, et al.
Published: (2014-01-01)

Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma
by: Rashi Garg, MD, et al.
Published: (2021-01-01)

Helical IMRT-Based Stereotactic Body Radiation Therapy Using an Abdominal Compression Technique and Modified Fractionation Regimen for Small Hepatocellular Carcinoma
by: Yi-Xing Chen MD, PhD, et al.
Published: (2020-07-01)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis
by: Peter Lee, BS, et al.
Published: (2020-09-01)

18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma
by: Ryan S. Youland, MD, et al.
Published: (2017-04-01)

Gantry-Mounted Linear Accelerator–Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
by: Audrey T. Dang, MD, et al.
Published: (2020-05-01)

Radiation Therapy Practice Patterns for Brain Metastases in the United States in the Stereotactic Radiosurgery Era
by: Andrew B. Barbour, PhD, et al.
Published: (2020-01-01)

Stereotactic body radiation therapy for adrenal gland metastases: Outcomes and toxicity
by: Diego A.S. Toesca, MD, et al.
Published: (2018-10-01)

Single fraction stereotactic radiosurgery for multiple brain metastases
by: Dror Limon, MD, et al.
Published: (2017-10-01)

Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy
by: Zhi Cheng, MD, MPH, et al.
Published: (2018-10-01)

Dosimetric Evaluation of Fractionated Stereotactic Radiation Therapy for Skull Base Meningiomas Using HyperArc and Multicriteria Optimization
by: Karen Chin Snyder, MS, et al.
Published: (2021-07-01)

Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era
by: Joseph Abi Jaoude, MD, et al.
Published: (2021-11-01)

Kilovoltage projection streaming-based tracking application (KiPSTA): First clinical implementation during spine stereotactic radiation surgery
by: Jihun Kim, PhD, et al.
Published: (2018-10-01)

Single-fraction Stereotactic Body Radiation Therapy versus Conventionally Fractionated Radiation Therapy for the Treatment of Prostate Cancer Bone Metastases
by: Robert W. Gao, BS, et al.
Published: (2019-04-01)

A comparison of interfraction setup error, patient comfort, and therapist acceptance for 2 different prostate radiation therapy immobilization devices
by: Eric Pei Ping Pang, MSc, et al.
Published: (2017-04-01)

Interobserver reliability in describing radiographic lung changes after stereotactic body radiation therapy
by: Noah S. Kalman, MD, MBA, et al.
Published: (2018-10-01)

The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery
by: Sara L. Thrower, PhD, et al.
Published: (2021-07-01)

Geometric Reproducibility of Fiducial Markers and Efficacy of a Patient-Specific Margin Design Using Deep Inspiration Breath Hold for Stereotactic Body Radiation Therapy for Pancreatic Cancer
by: Sarah Han-Oh, PhD, et al.
Published: (2021-03-01)

Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer
by: Shalini Moningi, MD, et al.
Published: (2021-03-01)

Recursive Partitioning Analysis for Local Control Achieved With Stereotactic Body Radiation Therapy for the Liver, Spine, or Lymph Nodes
by: Roman O. Kowalchuk, MD, et al.
Published: (2021-05-01)

In Silico Single-Fraction Stereotactic Ablative Radiation Therapy for the Treatment of Thoracic and Abdominal Oligometastatic Disease With Online Adaptive Magnetic Resonance Guidance
by: Sangjune Lee, MD, MSE, FRCPC, et al.
Published: (2021-05-01)

Radiation-Induced Lymphopenia Risks of Photon Versus Proton Therapy for Esophageal Cancer Patients
by: Saba Ebrahimi, BSc, et al.
Published: (2021-04-01)

The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity
by: Rachel B. Jimenez, MD, et al.
Published: (2017-07-01)

Ten-Year Experience of Stereotactic Body Radiotherapy at a Single Institution: Impact of Technological Development on the Outcome of Patients With Early Lung Cancer
by: Keiichiro Koiwai MD, PhD, et al.
Published: (2020-12-01)